Literature DB >> 33474692

miR-4319 inhibited retinoblastoma cells proliferation, migration, invasion and EMT progress via suppressing CD147 mediated MMPs expression.

Zhiqing Wu1, Ling Chen1, Chengyue Zhang2, Yanfang Liu3.   

Abstract

Tumor migration is the critical step that lead to the migration in retinoblastoma (RB), in which microRNAs (miRNAs) play important roles. This study aimed to investigate the role of microRNA-4319 (miR-4319) in the development of retinoblastoma by identifying its targets, as well as its underlying regulatory mechanisms. Our data shown that miR-4319 was downregulated in RB tissues and RB cell lines. Enhanced miR-4319 suppressed cell proliferation, migration, invasion and EMT progress, promoted cell apoptosis in SO-RB50 and RB-Y79 cells. Of note, extracellular matrix metalloproteinase inducer (EMMPRI/CD147) was identified as a direct target gene for miR-4319. MMPs were regulated by CD147 and participated in the miR-4319 regulatory network in SO-RB50 cells. In addition, overexpression of CD147 abrogated the inhibitory effect of miR-4319 on RB cells. In summary, miR-4319 overexpression suppressed cell proliferation, migration and invasion may through suppressing the CD147 mediated MMPs expression, suggesting that miR-4319 may serve as a potential diagnostic biomarker and treatment target for RB.

Entities:  

Keywords:  CD417; EMT; MMPs; Retinoblastoma; miRNA-4319

Mesh:

Substances:

Year:  2021        PMID: 33474692     DOI: 10.1007/s10735-020-09946-w

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  31 in total

Review 1.  MicroRNA functions in animal development and human disease.

Authors:  Ines Alvarez-Garcia; Eric A Miska
Journal:  Development       Date:  2005-11       Impact factor: 6.868

Review 2.  Risk factors for metastasis in retinoblastoma.

Authors:  Paul T Finger; J William Harbour; Zeynel A Karcioglu
Journal:  Surv Ophthalmol       Date:  2002 Jan-Feb       Impact factor: 6.048

3.  CD147 is required for matrix metalloproteinases-2 production and germ cell migration during spermatogenesis.

Authors:  Hao Chen; Kin Lam Fok; Sidney Yu; Jianli Jiang; Zhinan Chen; Yaoting Gui; Zhiming Cai; Hsiao Chang Chan
Journal:  Mol Hum Reprod       Date:  2011-02-22       Impact factor: 4.025

4.  Increased expression of MMP14 correlates with the poor prognosis of Chinese patients with gastric cancer.

Authors:  Yichen Dong; Guohua Chen; Mingming Gao; Xia Tian
Journal:  Gene       Date:  2015-03-04       Impact factor: 3.688

5.  Membrane type 1 matrix metalloproteinase (MT1-MMP/MMP-14) cleaves and releases a 22-kDa extracellular matrix metalloproteinase inducer (EMMPRIN) fragment from tumor cells.

Authors:  Nagayasu Egawa; Naohiko Koshikawa; Taizo Tomari; Kazuki Nabeshima; Toshiaki Isobe; Motoharu Seiki
Journal:  J Biol Chem       Date:  2006-10-18       Impact factor: 5.157

6.  MiR-4319 Suppress the Malignancy of Triple-Negative Breast Cancer by Regulating Self-Renewal and Tumorigenesis of Stem Cells.

Authors:  Jiahui Chu; Yongfei Li; Xuemei Fan; Jingjing Ma; Jun Li; Guangping Lu; Yanhong Zhang; Yi Huang; Wei Li; Xiang Huang; Ziyi Fu; Yongmei Yin; Hongyan Yuan
Journal:  Cell Physiol Biochem       Date:  2018-07-18

Review 7.  EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair.

Authors:  Eric E Gabison; Thanh Hoang-Xuan; Alain Mauviel; Suzanne Menashi
Journal:  Biochimie       Date:  2005 Mar-Apr       Impact factor: 4.079

8.  MMP14 predicts a poor prognosis in patients with colorectal cancer.

Authors:  Guangfei Cui; Feng Cai; Zhanwei Ding; Ling Gao
Journal:  Hum Pathol       Date:  2018-08-16       Impact factor: 3.466

9.  Expression of matrix metalloproteinases and their inhibitors in retinoblastoma.

Authors:  Mohan Adithi; Venkatesan Nalini; Mallikarjuna Kandalam; Subramanian Krishnakumar
Journal:  J Pediatr Hematol Oncol       Date:  2007-06       Impact factor: 1.289

10.  MicroRNA-133a regulates the mRNAs of two invadopodia-related proteins, FSCN1 and MMP14, in esophageal cancer.

Authors:  N Akanuma; I Hoshino; Y Akutsu; K Murakami; Y Isozaki; T Maruyama; G Yusup; W Qin; T Toyozumi; M Takahashi; H Suito; X Hu; N Sekino; H Matsubara
Journal:  Br J Cancer       Date:  2013-11-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.